Clinical Trial Update: The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)

View source ↗

Summary

Completed clinical trial evaluating heart rate variability using 24-hour Holter ECG and serum cardiac fibrosis markers in critically ill patients with cardiogen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Cardiogenic Shock,, With ECMO or IABP Support, | Status: COMPLETED